[1]
|
中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
|
[2]
|
杨燕, 王德峰. 肠道菌群在糖尿病治疗中的研究进展[J]. 临床荟萃, 2022, 37(10): 953-956.
|
[3]
|
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D.B., Morgun, A., et al. (2020) Role of Gut Microbiota in Type 2 Diabetes Pathophysiology. EBioMedicine, 51, Article ID: 102590. https://doi.org/10.1016/j.ebiom.2019.11.051
|
[4]
|
Han, J., Lin, H. and Huang, W. (2011) Modulating Gut Microbiota as an Anti-Diabetic Mechanism of Berberine. Medical Science Monitor, 17, RA164-RA167. https://doi.org/10.12659/msm.881842
|
[5]
|
Yang, F., Gao, R., Luo, X., Liu, R. and Xiong, D. (2023) Berberine Influences Multiple Diseases by Modifying Gut Microbiota. Frontiers in Nutrition, 10, Article ID: 1187718. https://doi.org/10.3389/fnut.2023.1187718
|
[6]
|
Habtemariam, S. (2020) Berberine Pharmacology and the Gut Microbiota: A Hidden Therapeutic Link. Pharmacological Research, 155, Article ID: 104722. https://doi.org/10.1016/j.phrs.2020.104722
|
[7]
|
Wu, J., Yang, K., Fan, H., Wei, M. and Xiong, Q. (2023) Targeting the Gut Microbiota and Its Metabolites for Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 14, Article ID: 1114424. https://doi.org/10.3389/fendo.2023.1114424
|
[8]
|
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., et al. (2019) Research Progress in the Relationship between Type 2 Diabetes Mellitus and Intestinal Flora. Biomedicine & Pharmacotherapy, 117, Article ID: 109138. https://doi.org/10.1016/j.biopha.2019.109138
|
[9]
|
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., et al. (2022) Gut Microbiota: A New Target for T2DM Prevention and Treatment. Frontiers in Endocrinology, 13, Article ID: 958218. https://doi.org/10.3389/fendo.2022.958218
|
[10]
|
Allin, K.H., Tremaroli, V., Caesar, R., Jensen, B.A.H., Damgaard, M.T.F., Bahl, M.I., et al. (2018) Aberrant Intestinal Microbiota in Individuals with Prediabetes. Diabetologia, 61, 810-820. https://doi.org/10.1007/s00125-018-4550-1
|
[11]
|
Letchumanan, G., Abdullah, N., Marlini, M., Baharom, N., Lawley, B., Omar, M.R., et al. (2022) Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 943427. https://doi.org/10.3389/fcimb.2022.943427
|
[12]
|
张勤, 龙沁, 邓玉玲, 等. 早发2型糖尿病肠道菌群分布特征研究[J]. 中国糖尿病杂志, 2023, 31(2): 113-119.
|
[13]
|
Chen, Y., Hao, Z., Zhao, H., Duan, X., Jia, D., Li, K., et al. (2022) Berberine Alleviates Intestinal Barrier Dysfunction in Glucolipid Metabolism Disorder Hamsters by Modulating Gut Microbiota and Gut‐Microbiota‐Related Tryptophan Metabolites. Journal of the Science of Food and Agriculture, 103, 1464-1473. https://doi.org/10.1002/jsfa.12242
|
[14]
|
Lv, Y., Zhao, X., Guo, W., Gao, Y., Yang, S., Li, Z., et al. (2018) The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. Journal of Diabetes Research, 2018, Article ID: 1890978. https://doi.org/10.1155/2018/1890978
|
[15]
|
Yao, Y., Chen, H., Yan, L., Wang, W. and Wang, D. (2020) Berberine Alleviates Type 2 Diabetic Symptoms by Altering Gut Microbiota and Reducing Aromatic Amino Acids. Biomedicine & Pharmacotherapy, 131, Article ID: 110669. https://doi.org/10.1016/j.biopha.2020.110669
|
[16]
|
McCreight, L.J., Bailey, C.J. and Pearson, E.R. (2016) Metformin and the Gastrointestinal Tract. Diabetologia, 59, 426-435. https://doi.org/10.1007/s00125-015-3844-9
|
[17]
|
Zhang, W., Xu, J., Yu, T. and Chen, Q. (2019) Effects of Berberine and Metformin on Intestinal Inflammation and Gut Microbiome Composition in Db/db Mice. Biomedicine & Pharmacotherapy, 118, Article ID: 109131. https://doi.org/10.1016/j.biopha.2019.109131
|
[18]
|
Lyu, Y., Zhang, Y., Yang, M., Lin, L., Yang, X., Cheung, S.C.K., et al. (2019) Pharmacokinetic Interactions between Metformin and Berberine in Rats: Role of Oral Administration Sequences and Microbiota. Life Sciences, 235, Article ID: 116818. https://doi.org/10.1016/j.lfs.2019.116818
|
[19]
|
王君君, 赖诚诚, 张曙光. 阿卡波糖对2型糖尿病肠道菌群及代谢产物的影响[J]. 中国糖尿病杂志, 2022, 30(8): 633-635.
|
[20]
|
Wang, S., Xu, Z., Cai, B., et al. (2021) Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), 21, 971-979. https://doi.org/10.2174/22123873mta52oduh1
|
[21]
|
He, Q., Dong, H., Guo, Y., Gong, M., Xia, Q., Lu, F., et al. (2022) Multi-Target Regulation of Intestinal Microbiota by Berberine to Improve Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article ID: 1074348. https://doi.org/10.3389/fendo.2022.1074348
|
[22]
|
Cheng, H., Liu, J., Tan, Y., Feng, W. and Peng, C. (2022) Interactions between Gut Microbiota and Berberine, a Necessary Procedure to Understand the Mechanisms of Berberine. Journal of Pharmaceutical Analysis, 12, 541-555. https://doi.org/10.1016/j.jpha.2021.10.003
|
[23]
|
Zhang, Z., Cong, L., Peng, R., Han, P., Ma, S., Pan, L., et al. (2021) Transformation of Berberine to Its Demethylated Metabolites by the CYP51 Enzyme in the Gut Microbiota. Journal of Pharmaceutical Analysis, 11, 628-637. https://doi.org/10.1016/j.jpha.2020.10.001
|
[24]
|
Yue, S., Liu, J., Wang, A., Meng, X., Yang, Z., Peng, C., et al. (2019) Berberine Alleviates Insulin Resistance by Reducing Peripheral Branched-Chain Amino Acids. American Journal of Physiology-Endocrinology and Metabolism, 316, E73-E85. https://doi.org/10.1152/ajpendo.00256.2018
|
[25]
|
Wang, H., Zhang, H., Gao, Z., Zhang, Q. and Gu, C. (2022) The Mechanism of Berberine Alleviating Metabolic Disorder Based on Gut Microbiome. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 854885. https://doi.org/10.3389/fcimb.2022.854885
|
[26]
|
Lyu, Y., Li, D., Yuan, X., Li, Z., Zhang, J., Ming, X., et al. (2022) Effects of Combination Treatment with Metformin and Berberine on Hypoglycemic Activity and Gut Microbiota Modulation in db/db Mice. Phytomedicine, 101, Article ID: 154099. https://doi.org/10.1016/j.phymed.2022.154099
|
[27]
|
Li, C., Cao, H., Huan, Y., Ji, W., Liu, S., Sun, S., et al. (2021) Berberine Combined with Stachyose Improves Glycometabolism and Gut Microbiota through Regulating Colonic MicroRNA and Gene Expression in Diabetic Rats. Life Sciences, 284, Article ID: 119928. https://doi.org/10.1016/j.lfs.2021.119928
|
[28]
|
Li, C., Wang, X., Lei, L., Liu, M., Li, R., Sun, S., et al. (2019) Berberine Combined with Stachyose Induces Better Glycometabolism than Berberine Alone through Modulating Gut Microbiota and Fecal Metabolomics in Diabetic Mice. Phytotherapy Research, 34, 1166-1174. https://doi.org/10.1002/ptr.6588
|
[29]
|
Wang, S., Ren, H., Zhong, H., Zhao, X., Li, C., Ma, J., et al. (2021) Combined Berberine and Probiotic Treatment as an Effective Regimen for Improving Postprandial Hyperlipidemia in Type 2 Diabetes Patients: A Double Blinded Placebo Controlled Randomized Study. Gut Microbes, 14, Article ID: 2003176. https://doi.org/10.1080/19490976.2021.2003176
|
[30]
|
Li, M., Zhou, W., Dang, Y., Li, C., Ji, G. and Zhang, L. (2020) Berberine Compounds Improves Hyperglycemia via Microbiome Mediated Colonic TGR5-GLP Pathway in db/db Mice. Biomedicine & Pharmacotherapy, 132, Article ID: 110953. https://doi.org/10.1016/j.biopha.2020.110953
|